1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204 
P ISUZU STRATEG'
Page 9
If you've noticed an error in this article please click here to report it so we can fix it.
Isuzu outlines ambitious growth plans
ISUZU MOTORS WILL to continue to flex its global muscles with anew, three-year plan that, if successful, will see it export 350,000 heavy/medium trucks and 420,000 light trucks by 2011. And it expects Isuzu Truck (UK) to double its sales volumes along the way.
Speaking at last week's launch of Isuzu Truck (UK)'s new middleweight rigid range (see page 30), the executive vice-president for Isuzu Motors, Coro Shintani, said: "In order to make that 350,000 units target take shape, we have assigned each market its share of the work, and Isuzu Motors expects Isuzu Truck (UK)'s sales volumes to reach 5,000 units a year, which is more than double this year's volume target."
Commenting on the Japanese truck-maker's latest three-year plan. Shintani said: "[It] is very challenging, it vs ill call for a consolidated yearly turnover of roughly LlObn, and a gross operating profit of £750m."
He added that lsuzu Motor's last three-year plan, completed at the end of March, yielded an "excellent outcome, fulfilling all the targets set out — namely £8.5bn in sales and an operating profit of around L500m".
According to Shintani: "We have generated cash and squeezed bank loans, and, consequently, we now have a very healthy balance sheet that makes it possible for us to allocate more and more resources into R&D."